Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Neuro3 Therapeutics | 2025 | Seed | $3.5M | Hong Kong |
| TOPI Imaging Technology | 2025 | Series E | $68.6M | Beijing |
| DH-Robotics | 2025 | Series Unknown | $13.7M | Shenzhen |
| Nanos Medical | 2025 | Series Unknown | $41.2M | Shanghai |
| Vivatides Therapeutics | 2025 | Seed | $10.0M | Woburn |
| Miguo AI | 2025 | Angel | $3.0M | Tianhe |
| Xi'an Dunbo Medical Equipment | 2025 | Series A | $5.5M | — |
| Xinzeyuan Medical | 2025 | Series B | $10.2M | Hangzhou |
| Insyce | 2025 | Series C | Undisclosed | Nanjing |
| Iongen Therepeutics | 2025 | Seed | $15.0M | Nanjing |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Neuro3 Therapeutics | Seed | $3.5M | Hong Kong, Hong Kong |
| 152 | TOPI Imaging Technology | Series E | $68.6M | Beijing, China |
| 153 | DH-Robotics | Series Unknown | $13.7M | Shenzhen, China |
| 154 | Nanos Medical | Series Unknown | $41.2M | Shanghai, China |
| 155 | Vivatides Therapeutics | Seed | $10.0M | Woburn, United States |
| 156 | Miguo AI | Angel | $3.0M | Tianhe, China |
| 157 | Xi'an Dunbo Medical Equipment | Series A | $5.5M | — |
| 158 | Xinzeyuan Medical | Series B | $10.2M | Hangzhou, China |
| 159 | Insyce | Series C | Undisclosed | Nanjing, China |
| 160 | Iongen Therepeutics | Seed | $15.0M | Nanjing, China |
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.
DH-Robotics provides a variety of intelligent grasping and precision motion products and solutions for customers in various industries.
Nanos Medical is a Healthcare Company.
Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
Miguo AI enhances artificial intelligence in various industries and transforms visual content creation.
Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices.
Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables.
Inces is a biotech enterprise focusing on bio-separation technology.
Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.
Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
NASN Automotive Electronics is a manufactures automotive electronics and driving related core technology products.
iMile is a logistics and delivery services provider across the Middle East.
The company is currently operating in Stealth Mode.
Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related products and devices.
Scroll.io provides a native zkEVM scaling solution for Ethereum.
ZD Medical is a medical device company that manufactures optical coherence tomography angiography devices.
Bioyond Tech utilizes robotics and artificial intelligence technology to provide modular products and automation solutions.
IntoCare is a high-tech company specializing in surgical products.
LaNova Medicines is a clinical-stage innovative drug research and development company.
Tachem is a research and development manufacturer of protected amino acid series products.
Hope Medicine is a science-driven clinical stage biopharmaceutical company
Original Point focuses on the development of CNC systems with five-axis and multi-axis linkage capabilities.
Viewtrix Technology develops display driver chips and circuit boards, supporting various types of OLED display screens.
Qiming Venture Partners has invested in 395 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Medical, Health Care, Medical Device, Biotechnology, Artificial Intelligence (AI). The firm invests across 32 different industry categories.
Among tracked funding rounds, Windward Bio received $200.0M in a Series A round. Qiming Venture Partners's total known invested capital is $14.8B.
Qiming Venture Partners's average investment size is $59.1M across its portfolio of 395 companies.
Recent Qiming Venture Partners portfolio additions include Neuro3 Therapeutics, TOPI Imaging Technology, DH-Robotics, Nanos Medical, Vivatides Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors